EDSA logo

Edesa Biotech (EDSA)

Profile

Full Name

Edesa Biotech, Inc.

Ticker Symbol

EDSA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

June 21, 2010

Indexes

Not included

Website

http://www.edesabiotech.com

Employees

16

Key Details

Price

$2.25(+2.27%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.93(-361.06% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.25
EDSA price is $2.25

30-Day Relative Volume

0.13
EDSA 30-day relative volume is 0.13

Price Performance

Price Most recent change

+2.27%
EDSA price was up +2.27% on Apr 11, 2025

Price YTD change

+33.93%
EDSA price is up +33.93% since January 1st

Price 1-year change

-49.78%
EDSA price is down -49.78% year-on-year

Price 3-year change

-88.48%
EDSA price is down -88.48% over the past 3 years

Price Range

Price All-time high

$6938.40
EDSA price is currently -99.97% below its historical high of $6938.40

Price 3-year low

$1.55
EDSA price is currently +45.16% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$15.80M
EDSA market capitalization is $15.80 million

Market cap 3-year change

-63.37%
EDSA market capitalization is down -63.37% over the past 3 years

Market cap All-time high

$514.50M
EDSA market capitalization is currently -96.93% below its historical high of $514.50 million

Market cap sector rank

25.47%
EDSA market capitalization is higher than 25.47% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+118.37%
EDSA shares outstanding is up +118.37% year-on-year

Shares Outstanding 3-Year Change

+217.93%
EDSA shares outstanding is up +217.93% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.71
EDSA beta is 0.71

200-day SMA

$3.16
EDSA price is currently -28.76% below its 200-day simple moving average

50-day SMA

$2.30
EDSA price is currently -2.17% below its 50-day simple moving average

RSI

45.75
EDSA 14-day relative strength index is 45.75

Volume

0.13
EDSA 30-day relative volume is 0.13

ATR

$0.15
EDSA average true range is $0.15

10-day Historical Volatility

58.28%
EDSA 10-day historical volatility is 58.28%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
EDSA annual revenue value is unknown

Revenue Analysts estimate

-
EDSA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
EDSA annual revenue 1-year change is unknown

Revenue Sector rank

-
EDSA annual revenue is unknown

EPS

EPS

-$1.93
EDSA annual earnings per share is -$1.93

EPS Analysts estimate

-$1.93
EDSA annual earnings per share is currently equal to the consensus analysts' forecast

EPS 1-year change

-361.06%
EDSA annual earnings per share is down -361.06% year-on-year

EPS Sector rank

39.39%
EDSA annual earnings per share is higher than 39.39% of companies in Healthcare sector

Profit

Gross profit

-
EDSA annual gross profit value is unknown

Gross margin

-
EDSA annual gross profit margin value is unknown

Operating profit

-$6.32M
EDSA annual operating income is -$6.32 million

Operating margin

-
EDSA annual operating profit margin value is unknown

Net income

-$6.17M
EDSA annual net profit is -$6.17 million

Net margin

-
EDSA annual net profit margin value is unknown

Expenses

Total expenses

$6.32M
EDSA annual total expenses is $6.32 million

Operating expenses

$6.32M
EDSA annual total operating expenses is $6.32 million

Cost of goods sold

-
EDSA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.13M
EDSA annual SGA is $4.13 million

Depreciation and amortization

$186.00K
EDSA annual depreciation & amortization is $186.00 thousand

Interest expense

-
EDSA annual interest expense value is unknown

Income tax

$800.00
EDSA annual income tax is $800.00

EBIT & EBITDA

EBIT

-$6.32M
EDSA annual earnings before interest & taxes is -$6.32 million

EBITDA

-$6.13M
EDSA annual EBITDA is -$6.13 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.81M
EDSA annual total assets is $3.81 million

Non current assets

$2.14M
EDSA annual long term assets is $2.14 million

Current assets

$1.68M
EDSA annual total current assets is $1.68 million

Cash and cash equivalents

$1.04M
EDSA annual cash & cash equivalents is $1.04 million

Accounts receivable

$270.90K
EDSA annual accounts receivable is $270.90 thousand

Inventory

-
EDSA annual inventory value is unknown

Liabilities

Total liabilities

$1.83M
EDSA annual total liabilities is $1.83 million

Long term liabilities

$0.00
EDSA annual total long term liabilities is $0.00

Current liabilities

$1.83M
EDSA annual total current liabilities is $1.83 million

Accounts payable

-
EDSA annual accounts payable value is unknown

Debt

Total debt

$19.90K
EDSA annual total debt is $19.90 thousand

Total debt 1-year change

-78.94%
EDSA annual total debt is down -78.94% year-on-year

Long term debt

$0.00
EDSA annual long term debt is $0.00

Short term debt

$19.90K
EDSA annual short term debt is $19.90 thousand

Equity & Capital

Shareholders equity

$1.98M
EDSA annual stockholders equity is $1.98 million

Book value

$1.98M
EDSA annual book value is $1.98 million

Retained earnings

-$58.59M
EDSA annual retained earnings is -$58.59 million

Working capital

-$157.20K
EDSA annual working capital is -$157.20 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$4.89M
EDSA annual cash flow from operations is -$4.89 million

Cash from operations 1-year change

+26.31%
EDSA annual cash flow from operations is up +26.31% year-on-year

Cash from investing

-
EDSA annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
EDSA annual cash flow from investing activities 1-year change is unknown

Cash from financing

$592.00K
EDSA annual cash flow from financing activities is $592.00 thousand

Cash from financing 1-year change

-87.74%
EDSA annual cash flow from financing activities is down -87.74% year-on-year

CAPEX

CAPEX

-
EDSA annual capital expenditures value is unknown

CAPEX 1-year change

-
EDSA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$4.89M
EDSA annual free cash flow is -$4.89 million

Free cash flow 1-year change

+26.31%
EDSA annual free cash flow is up +26.31% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
EDSA annual gross profit margin value is unknown

Operating margin

-
EDSA annual operating profit margin value is unknown

Net margin

-
EDSA annual net profit margin value is unknown

ROA & ROE

ROA

-161.77%
EDSA annual return on assets is -161.77%

ROE

-311.43%
EDSA annual return on equity is -311.43%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
EDSA price to earnings ratio value is unknown

PE ratio Sector rank

-
EDSA price to earnings ratio is unknown

PB Ratio

PB ratio

12.32
EDSA price to book ratio is 12.32

PB ratio Sector rank

94.65%
EDSA price to book ratio is higher than 94.65% of companies in Healthcare sector

PS Ratio

PS ratio

-
EDSA price to sales ratio value is unknown

PS ratio Sector rank

-
EDSA price to sales ratio is unknown

Enterprise value

Enterprise value

$14.24M
EDSA enterprise value is $14.24 million

Enterprise value Sector rank

29.15%
EDSA enterprise value is higher than 29.15% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.38
EDSA EV/EBITDA is -2.38

EV/EBITDA Sector rank

28.5%
EDSA EV/EBITDA is higher than 28.5% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.91
EDSA annual current ratio is 0.91

Quick ratio

-
EDSA annual quick ratio value is unknown

Leverage

Debt to equity

0.01
EDSA annual debt to equity ratio is 0.01

Interest coverage ratio

-
EDSA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
EDSA piotroski f-score value is unknown

Altman Z-Score

-
EDSA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 13, 25 HC Wainwright & Co.
Buy
Nov 29, 23 HC Wainwright & Co.
Buy
Nov 22, 23 HC Wainwright & Co.
Buy
Oct 12, 23 Brookline Capital
Buy
Aug 15, 23 HC Wainwright & Co.
Buy
May 24, 23 HC Wainwright & Co.
Buy
Mar 15, 23 HC Wainwright & Co.
Buy
Feb 14, 23 HC Wainwright & Co.
Buy
Dec 20, 21 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

IINN logo
Inspira Technologies Oxy BHN (IINN)
Quantum BioPharma (QNTM)
IRIX logo
IRIDEX (IRIX)
EGRX logo
Eagle Pharmaceuticals (EGRX)
BCTX logo
BriaCell Therapeutics (BCTX)
SNYR logo
Synergy CHC (SNYR)
MODV logo
ModivCare (MODV)
VSee Health (VSEE)
LFWD logo
ReWalk Robotics (LFWD)
  • What is the ticker symbol for Edesa Biotech?
  • Does Edesa Biotech pay dividends?
  • What sector is Edesa Biotech in?
  • What industry is Edesa Biotech in?
  • What country is Edesa Biotech based in?
  • When did Edesa Biotech go public?
  • Is Edesa Biotech in the S&P 500?
  • Is Edesa Biotech in the NASDAQ 100?
  • Is Edesa Biotech in the Dow Jones?
  • When was Edesa Biotech's last earnings report?
  • When does Edesa Biotech report earnings?
  • Should I buy Edesa Biotech stock now?

What is the ticker symbol for Edesa Biotech?

The ticker symbol for Edesa Biotech is NASDAQ:EDSA

Does Edesa Biotech pay dividends?

No, Edesa Biotech does not pay dividends

What sector is Edesa Biotech in?

Edesa Biotech is in the Healthcare sector

What industry is Edesa Biotech in?

Edesa Biotech is in the Biotechnology industry

What country is Edesa Biotech based in?

Edesa Biotech is headquartered in Canada

When did Edesa Biotech go public?

Edesa Biotech's initial public offering (IPO) was on June 21, 2010

Is Edesa Biotech in the S&P 500?

No, Edesa Biotech is not included in the S&P 500 index

Is Edesa Biotech in the NASDAQ 100?

No, Edesa Biotech is not included in the NASDAQ 100 index

Is Edesa Biotech in the Dow Jones?

No, Edesa Biotech is not included in the Dow Jones index

When was Edesa Biotech's last earnings report?

Edesa Biotech's most recent earnings report was on Feb 14, 2025

When does Edesa Biotech report earnings?

The next expected earnings date for Edesa Biotech is May 9, 2025

Should I buy Edesa Biotech stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page